{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:26:15Z","timestamp":1773422775150,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":5326,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1194\/jlr.m500276-jlr200","type":"journal-article","created":{"date-parts":[[2005,11,21]],"date-time":"2005-11-21T01:12:42Z","timestamp":1132535562000},"page":"349-355","source":"Crossref","is-referenced-by-count":22,"title":["Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer"],"prefix":"10.1016","volume":"47","author":[{"given":"Jonathan Q.","family":"Purnell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa B.","family":"Bland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Garzotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne","family":"Lemmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M.","family":"Wersinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher W.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Brunzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz M.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M500276-JLR200_bib1","first-page":"293","article-title":"Studies in prostatic cancer. I. The effect of castration on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res."},{"key":"10.1194\/jlr.M500276-JLR200_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M500276-JLR200_bib3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer","volume":"341","author":"Messing","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M500276-JLR200_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0360-3016(01)01579-6","article-title":"Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate","volume":"50","author":"Pilepich","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1194\/jlr.M500276-JLR200_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/95.13.981","article-title":"National practice patterns and time trends in androgen ablation for localized prostate cancer","volume":"95","author":"Cooperberg","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1194\/jlr.M500276-JLR200_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology."},{"key":"10.1194\/jlr.M500276-JLR200_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","article-title":"Progressive osteoporosis during androgen deprivation therapy for prostate cancer","volume":"163","author":"Daniell","year":"2000","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib8","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0022-5347(05)64985-3","article-title":"Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy","volume":"167","author":"Berruti","year":"2002","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib9","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jcem.86.9.7851","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"Smith","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(96)05864-9","article-title":"The relationship of natural androgens to coronary heart disease in males: a review","volume":"125","author":"Alexandersen","year":"1996","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M500276-JLR200_bib12","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2337\/diacare.26.6.1869","article-title":"Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes","volume":"26","author":"Fukui","year":"2003","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.M500276-JLR200_bib13","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.ju.0000127740.96006.1a","article-title":"Changing patterns in competing causes of death in men with prostate cancer: a population based study","volume":"171","author":"Lu-Yao","year":"2004","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0026-0495(87)90183-1","article-title":"Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma","volume":"36","author":"Moorjani","year":"1987","journal-title":"Metabolism."},{"key":"10.1194\/jlr.M500276-JLR200_bib15","first-page":"1336","article-title":"Effect of surgical castration on risk factors for arteriosclerosis of patients with prostate cancer","volume":"115","author":"Xu","year":"2002","journal-title":"Chin. Med. J. (Engl.)."},{"key":"10.1194\/jlr.M500276-JLR200_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2007-1019247","article-title":"Plasma lipoproteins during anti-androgen treatment by estrogens or orchidectomy in men with prostatic carcinoma","volume":"13","author":"Wallentin","year":"1981","journal-title":"Horm. Metab. Res."},{"key":"10.1194\/jlr.M500276-JLR200_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0022-5347(17)49991-5","article-title":"The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma","volume":"132","author":"Agardh","year":"1984","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0090-4295(82)90345-4","article-title":"Serum lipid changes after estrogen therapy in prostatic carcinoma","volume":"20","author":"Bulusu","year":"1982","journal-title":"Urology."},{"key":"10.1194\/jlr.M500276-JLR200_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/1097-0142(197609)38:3<1095::AID-CNCR2820380309>3.0.CO;2-Z","article-title":"Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer","volume":"38","author":"Seal","year":"1976","journal-title":"Cancer."},{"key":"10.1194\/jlr.M500276-JLR200_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.1973.03230060030009","article-title":"The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group","volume":"226","year":"1973","journal-title":"J. Am. Med. Assoc."},{"key":"10.1194\/jlr.M500276-JLR200_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-5347(17)45620-5","volume":"135","author":"de Voogt","year":"1986","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1194\/jlr.M500276-JLR200_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M500276-JLR200_bib24","doi-asserted-by":"crossref","first-page":"RC12","DOI":"10.1007\/BF03345282","article-title":"Meal intake similarly reduces circulating concentrations of octanoyl and total ghrelin in humans","volume":"27","author":"Lucidi","year":"2004","journal-title":"J. Endocrinol. Invest."},{"key":"10.1194\/jlr.M500276-JLR200_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1464-410X.1990.tb14728.x","article-title":"Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma","volume":"65","author":"Henriksson","year":"1990","journal-title":"Br. J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib26","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/01.ju.0000061024.75334.40","article-title":"Transdermal estradiol therapy for advanced prostate cancer\u2014forward to the past?","volume":"169","author":"Ockrim","year":"2003","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/cncr.20857","article-title":"Phase II study of transdermal estradiol in androgen-independent prostate carcinoma","volume":"103","author":"Bland","year":"2005","journal-title":"Cancer."},{"key":"10.1194\/jlr.M500276-JLR200_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","article-title":"Enzymatic methods for quantification of lipoprotein lipids","volume":"129","author":"Warnick","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1194\/jlr.M500276-JLR200_bib29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.M500276-JLR200_bib30","series-title":"Laboratory Measurement of Lipids, Lipoproteins, and Apolipoproteins","first-page":"207","article-title":"Measurement and clinical significance of high-density lipoprotein cholesterol subclasses","author":"Warnick","year":"1994"},{"key":"10.1194\/jlr.M500276-JLR200_bib31","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/40.4.586","article-title":"International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material","volume":"40","author":"Marcovina","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.M500276-JLR200_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/01.ATV.9.3.319","article-title":"Large buoyant LDL-like particles in hepatic lipase deficiency","volume":"9","author":"Auwerx","year":"1989","journal-title":"Arteriosclerosis."},{"key":"10.1194\/jlr.M500276-JLR200_bib33","first-page":"E107","article-title":"Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme","volume":"249","author":"Iverius","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1194\/jlr.M500276-JLR200_bib34","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1086\/375878","article-title":"Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression","volume":"37 (Suppl. 2)","author":"Bhasin","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1194\/jlr.M500276-JLR200_bib36","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M500276-JLR200_bib37","first-page":"855","article-title":"Physiological levels of estradiol stimulate plasma high density lipoprotein2 cholesterol levels in normal men","volume":"78","author":"Bagatell","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/003655902762467549","article-title":"Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer\u2014Scandinavian Prostatic Cancer Group (SPCG) study no. 5","volume":"36","author":"Hedlund","year":"2002","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1194\/jlr.M500276-JLR200_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen\/Progestin Interventions (PEPI) study","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation."},{"key":"10.1194\/jlr.M500276-JLR200_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.0000115383.49802.0c","article-title":"Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women","volume":"24","author":"Wakatsuki","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M500276-JLR200_bib41","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","article-title":"Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial","volume":"17","author":"Scarabin","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M500276-JLR200_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1194\/jlr.M500276-JLR200_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0037-1613608","article-title":"Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein","volume":"90","author":"Lacut","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1194\/jlr.M500276-JLR200_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0022-5347(17)61644-6","article-title":"Effect of estrogen on the serum cholesterol and triglyceride levels of prostatic cancer patients","volume":"105","author":"Kontturi","year":"1971","journal-title":"J. Urol."},{"key":"10.1194\/jlr.M500276-JLR200_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/bmj.2.5865.512","article-title":"Metabolic effects of oestrogen treatment in patients with carcinoma of prostate: a comparison of stilboestrol and conjugated equine oestrogens","volume":"2","author":"Shahmanesh","year":"1973","journal-title":"Br. Med. J."},{"key":"10.1194\/jlr.M500276-JLR200_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365597509180912","article-title":"Serum lipid levels and thromboembolic complications during estrogen therapy of prostatic cancer","volume":"9","author":"Sotanieme","year":"1975","journal-title":"Scand. J. Urol. Nephrol."},{"key":"10.1194\/jlr.M500276-JLR200_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M500276-JLR200_bib48","first-page":"2831","article-title":"The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low\/high density lipoprotein heterogeneity","volume":"86","author":"Carr","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib49","first-page":"157","article-title":"Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial","volume":"5","author":"Meschia","year":"1998","journal-title":"Menopause."},{"key":"10.1194\/jlr.M500276-JLR200_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0021-9150(03)00088-1","article-title":"Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis","volume":"168","author":"Zegura","year":"2003","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M500276-JLR200_bib51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2004.04846.x","article-title":"Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers","volume":"124","author":"Stevenson","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1194\/jlr.M500276-JLR200_bib52","first-page":"579","article-title":"Sexual dimorphism in plasma leptin concentration","volume":"82","author":"Saad","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib53","first-page":"3267","article-title":"Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals","volume":"82","author":"Elbers","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.M500276-JLR200_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/oxfordjournals.aje.a009317","article-title":"Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy","volume":"146","author":"Haffner","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1194\/jlr.M500276-JLR200_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00042192-200201000-00010","article-title":"Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study","volume":"9","author":"Cagnacci","year":"2002","journal-title":"Menopause."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752033635X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002222752033635X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M500276-JLR200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T17:37:57Z","timestamp":1637429877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002222752033635X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S002222752033635X"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m500276-jlr200","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}